Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Butler John P. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2023 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 38,259 shares @ $0.8775, valued at $33.6k
Sold 47,239 shares @ $0.8775, valued at $41.5k
Sold 6,370 shares @ $0.8775, valued at $5.6k
03/01/2023 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 38,632 shares @ $0.8132, valued at $31.4k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/05/2021 4 Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 5,000 shares @ $0
Granted 7,500 options to buy @ $4.44, valued at $33.3k
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $5.21, valued at $78.2k
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2019 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Bought 50,000 shares @ $3.44, valued at $172k
06/13/2019 4 Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $13.5, valued at $202.5k
06/05/2019 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Exercised 287,000 options to buy @ $0.47, valued at $134.9k
12/13/2018 4 Butler John P. (CEO & President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Paid exercise price by delivering 135,697 shares @ $8.94, valued at $1.2M
08/22/2018 4 Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $6.4306, valued at $32.2k
07/12/2018 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Exercised 100,000 options to buy @ $0.47, valued at $47k
06/07/2018 4 Butler John P. (Director) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $11.3, valued at $169.5k
04/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2018 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 88,900 shares @ $0
Granted 126,300 options to buy @ $14.3, valued at $1.8M
06/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/02/2016 4 Butler John P. (Director) has filed a Form 4 on Relypsa Inc
Txns: Unknown transaction of 2,849 shares @ $32, valued at $91.2k
Disposed/sold 2,250 shares @ $32, valued at $72k
Disposed/sold 24,632 options to buy @ $11, valued at $271k
Disposed/sold 3,828 options to buy @ $23.96, valued at $91.7k
Disposed/sold 4,500 options to buy @ $35.79, valued at $161.1k
Disposed/sold 4,500 options to buy @ $17, valued at $76.5k
06/23/2016 4 Butler John P. (Director) has filed a Form 4 on Relypsa Inc
Txns: Granted 2,250 shares @ $0
Granted 4,500 options to buy @ $17, valued at $76.5k
06/08/2016 4 Butler John P. (Director) has filed a Form 4 on Relypsa Inc
Txns: Sold 1,013 shares @ $19.3192, valued at $19.6k
05/27/2016 4 Butler John P. (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 10,000 shares @ $0
Granted 30,000 options to buy @ $5.71, valued at $171.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy